Fernandez, Ana .

HRN: 22-12-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/29/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/29/2022
01/04/2023
IVT
500mg
Q8
T/C Hepatic Encephalopathy
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Central Nervous System    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: